SCP
CPRX

Seizert Capital Partners’s Catalyst Pharmaceutical CPRX Stock Holding History

Seizert Capital Partners’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$334K Buy
+13,500
New +$322K 0.02% 147
2020
Q4 		– Sell
-77,523
Closed -$230K – 193
2020
Q3 		$230K Buy
77,523
+32,015
+70% +$125K 0.02% 165
2020
Q2 		$210K Buy
+45,508
New +$204K 0.01% 184

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Seizert Capital Partners's CPRX Position: Q1 2026 in Review

Seizert Capital Partners opened a new position in Catalyst Pharmaceutical (CPRX) in Q1 2026: 13,500 shares worth $334K. The stake represents 0.02% of the portfolio and ranks #147 among its holdings. This is a return to the name: Seizert Capital Partners previously reported a position in CPRX as recently as Q3 2020.

Seizert Capital Partners first reported a position in CPRX in Q2 2020 and has held it in 3 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Seizert Capital Partners held 13,500 shares of Catalyst Pharmaceutical worth $334K as of Q1 2026.
  • Catalyst Pharmaceutical was a new Seizert Capital Partners position in Q1 2026.
  • Catalyst Pharmaceutical made up 0.02% of Seizert Capital Partners's portfolio in Q1 2026, its #147 holding.
  • Seizert Capital Partners first reported a position in Catalyst Pharmaceutical in Q2 2020 and has held it in 3 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.